日本語English简体中文 繁體中文

01177 Sino Biopharmaceutical Ltd.SBP GROUPHong Kong Stock Exchange

11 posts

Sino Biopharmaceutical Ltd. (01177) at a glance

Code
01177
Company
Sino Biopharmaceutical Ltd.
Local name
SBP GROUP
Market
Hong Kong Stock Exchange
Share price
HK$5.54 -0.02 (-0.36%) Nov 11 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Sino Biopharmaceutical Ltd. (01177) Stock Price History

Sino Biopharmaceutical Ltd. closed at HK$5.54 on Nov 11, 2026, +2.3% over 1 month, −19.4% over 1 year.

2026-10-14 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 A…2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT I…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "…2026-10-27 事業の状況 VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE P…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGE…2026-11-09 事業の状況 VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AG…HK$5.63HK$4.76Oct 12Nov 11
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$5.63Nov 5
1-Month LowHK$4.76Oct 27
1-Week Change+7.5%vs Nov 4
1-Month Change+2.3%vs Oct 9

If you had invested HK$10,000 1 month ago, it would be worth HK$10,250 today (+2.5%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +0.2%, while this stock moved +2.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 11 (Wed)HK$5.54−0.02−0.36%
Nov 10 (Tue)HK$5.56+0.09+1.55%
Nov 9 (Mon)HK$5.47−0.13−2.32%
Nov 6 (Fri)HK$5.60−0.03−0.44%
Nov 5 (Thu)HK$5.63+0.48+9.22%
Nov 4 (Wed)HK$5.15+0.27+5.42%
Nov 3 (Tue)HK$4.89+0.02+0.41%
Nov 2 (Mon)HK$4.87+0.04+0.93%
Oct 30 (Fri)HK$4.82−0.03−0.62%
Oct 29 (Thu)HK$4.85−0.01−0.10%
2026-09-16 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQB2… / 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQH2…2026-09-24 中間報告書 2026 INTERIM REPORT2026-09-28 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHI…2026-10-08 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL SUBJECTS ENROLLMENT IN TH…2026-10-14 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 A…2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT I…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "…2026-10-27 事業の状況 VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE P…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGE…2026-11-09 事業の状況 VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AG…HK$5.92HK$4.76Aug 11Nov 11
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$5.92Sep 21
3-Month LowHK$4.76Oct 27
1-Month Change+2.3%vs Oct 9
3-Month Change+10.7%vs Aug 11

If you had invested HK$10,000 3 months ago, it would be worth HK$11,070 today (+10.7%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −5.2%, while this stock moved +10.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 11 (Wed)HK$5.54−0.02−0.36%
Nov 10 (Tue)HK$5.56+0.09+1.55%
Nov 9 (Mon)HK$5.47−0.13−2.32%
Nov 6 (Fri)HK$5.60−0.03−0.44%
Nov 5 (Thu)HK$5.63+0.48+9.22%
Nov 4 (Wed)HK$5.15+0.27+5.42%
Nov 3 (Tue)HK$4.89+0.02+0.41%
Nov 2 (Mon)HK$4.87+0.04+0.93%
Oct 30 (Fri)HK$4.82−0.03−0.62%
Oct 29 (Thu)HK$4.85−0.01−0.10%
2026-09-16 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQB2… / 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQH2…2026-09-24 中間報告書 2026 INTERIM REPORT2026-09-28 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHI…2026-10-08 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL SUBJECTS ENROLLMENT IN TH…2026-10-14 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 A…2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT I…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "…2026-10-27 事業の状況 VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE P…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGE…2026-11-09 事業の状況 VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AG…HK$5.92HK$4.26May 11Nov 11
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$5.92Sep 21
6-Month LowHK$4.26Jun 25
3-Month Change+10.7%vs Aug 11
6-Month Change−2.2%vs May 11

If you had invested HK$10,000 6 months ago, it would be worth HK$9,779 today (−2.2%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −7.9%, while this stock moved −2.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$5.54+14.8%
Oct 2026HK$4.82−15.6%
Sep 2026HK$5.71+4.8%
Aug 2026HK$5.45+8.3%
Jul 2026HK$5.03+14.1%
Jun 2026HK$4.41−11.6%
May 2026HK$4.99−7.9%
2026-09-16 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQB2… / 事業の状況 VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQH2…2026-09-24 中間報告書 2026 INTERIM REPORT2026-09-28 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHI…2026-10-08 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL SUBJECTS ENROLLMENT IN TH…2026-10-14 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 A…2026-10-21 事業の状況 VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT I…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "…2026-10-27 事業の状況 VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE P…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGE…2026-11-09 事業の状況 VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AG…HK$7.37HK$4.26Nov 11Nov 11
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$7.37Nov 13
52-Week LowHK$4.26Jun 25
Year to Date−10.4%vs Dec 31
From 52-Week High−24.9%Nov 13

If you had invested HK$10,000 1 year ago, it would be worth HK$8,057 today (−19.4%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.9%, while this stock moved −19.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$5.54+14.8%
Oct 2026HK$4.82−15.6%
Sep 2026HK$5.71+4.8%
Aug 2026HK$5.45+8.3%
Jul 2026HK$5.03+14.1%
Jun 2026HK$4.41−11.6%
May 2026HK$4.99−7.9%
Apr 2026HK$5.42−8.0%
Mar 2026HK$5.89−2.6%
Feb 2026HK$6.05−8.9%
Jan 2026HK$6.64+7.4%
Dec 2025HK$6.18−12.3%
Nov 2025HK$7.05−0.3%
HK$8.91HK$2.34Nov 13, 2023Nov 11, 2026
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$8.91Sep 1, 2025
3-Year LowHK$2.34Apr 15, 2024
Annualized Return+13.1%
Max Drawdown−52.2%

If you had invested HK$10,000 3 years ago, it would be worth HK$14,452 today (+44.5%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +39.3%, while this stock moved +44.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.54−10.4%
2025HK$6.18―
HK$8.91HK$2.34Nov 15, 2021Nov 11, 2026
Price13-week MA26-week MAHang Seng Index
5-Year HighHK$8.91Sep 1, 2025
5-Year LowHK$2.34Apr 15, 2024
Annualized Return−0.9%
Max Drawdown−62.0%

If you had invested HK$10,000 5 years ago, it would be worth HK$9,543 today (−4.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −2.9%, while this stock moved −4.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.54−10.4%
2025HK$6.18―
HK$10.10HK$0.09Jun 1, 2004Nov 11, 2026
Price1-year MA2-year MAHang Seng Index
All-Time HighHK$10.10Jul 2020
All-Time LowHK$0.09Jun 2004
Total Change+5,788.3%vs Jun 2004
Annualized Return+19.9%

If you had invested HK$10,000 in Jun 2004, it would be worth HK$588,830 today (+5,788.3%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +89.2%, while this stock moved +5,788.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.54−10.4%
2025HK$6.18+91.9%
2024HK$3.22−7.2%
2023HK$3.47−24.1%
2022HK$4.57−16.3%
2021HK$5.46−27.7%
2020HK$7.55+3.9%
2019HK$7.27+111.3%
2018HK$3.44−44.2%
2017HK$6.16+153.8%
2016HK$2.43−22.7%
2015HK$3.14+50.6%
2014HK$2.08+14.3%
2013HK$1.82+66.2%
2012HK$1.10+60.2%
2011HK$0.68−20.1%
2010HK$0.86+15.5%
2009HK$0.74+375.0%
2008HK$0.16−27.4%
2007HK$0.22+58.1%
2006HK$0.14−42.4%
2005HK$0.24+51.3%
2004HK$0.16―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2004). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.11 Disclosure 2026/11/09 09:01
事業の状況
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AGONIST" PRESENTED AT THE 2026 AASLD
Delete
No.10 Disclosure 2026/11/04 17:34
事業の状況
VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGELHEIM WITH POTENTIAL TOTAL DEAL VALUE OF US$7 BILLION
Delete
No.9 Disclosure 2026/10/27 08:54
事業の状況
VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE PROTEIN ALLOSTERIC MODULATOR" GRANTED BREAKTHROUGH THERAPY DESIGNATION BY CDE
Delete
No.8 Disclosure 2026/10/26 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "HER2 BIPARATOPIC ADC" PRESENTED AT 2026 ESMO
Delete
No.7 Disclosure 2026/10/21 08:54
事業の状況
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT IN THE PHASE III REGISTRATIONAL CLINICAL TRIAL OF TQC2731 INJECTION "TSLP MONOCLONAL ANTIBODY" FOR CHRONIC SINUSITIS WITH NASAL POLYPS
Delete
No.6 Disclosure 2026/10/14 19:20
事業の状況
VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 AGONIST" AND BEPIROVIRSEN "ASO" TO BE PRESENTED AT 2026 AASLD
Delete
No.5 Disclosure 2026/10/08 18:30
事業の状況
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL SUBJECTS ENROLLMENT IN THE PHASE III REGISTRATIONAL CLINICAL TRIAL OF TQC3721 INHALATION SUSPENSION "PDE3/4 INHIBITOR"
Delete
No.4 Disclosure 2026/09/28 17:45
事業の状況
VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHIP WITH STADA
Delete
No.3 Disclosure 2026/09/24 17:51
中間報告書
2026 INTERIM REPORT
Delete
No.2 Disclosure 2026/09/16 08:07
事業の状況
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQH2722 INJECTION
Delete
No.1 Disclosure 2026/09/16 08:03
事業の状況
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQB2102 INJECTION "HER2 BISPECIFIC ADC"
Delete

Write on the Sino Biopharmaceutical Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English